Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal gland development

被引:41
作者
Chamoux, E
Breault, L
Lehoux, JG
Gallo-Payet, N
机构
[1] Univ Sherbrooke, Fac Med, Dept Med, Serv Endocrinol, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Fac Med, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada
关键词
D O I
10.1210/jc.84.12.4722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to establish a link between the highly expressed angiotensin II (Ang II) type 2 receptor (AT(2)) in human fetal adrenal cells and the proposed apoptotic activity in the center of the gland. There was an important increase in apoptotic DNA fragmentation with age in adrenal glands of fetuses from 15-20 weeks gestation. Adrenal cells showing the characteristic apoptotic internucleosomal DNA fragmentation were localized in the central portion of the fetal zone. In cells cultured for 24 h, Ang II, via the AT(2) receptor, induced DNA fragmentation and cleavage of the DNA repair enzyme, poly-(ADP-ribose) polymerase. Furthermore, characteristic membrane blebbing was observed specifically on cells of the fetal zone. Immunofluorescence studies demonstrated that stimulation with Ang II or CGP 42112 (an agonist of the AT(2) receptor) strongly modified the actin network, now localized exclusively along the plasma membrane, with a predominance of labeling at the base of the bleb formation. This rearrangement of actin distribution was different in cells from the definitive zone, corroborating the observation that these cells express many more Ang II type 1 receptors (AT(1)) than AT(2) receptors. Taken together, our data indicate that the AT(2) receptor is involved in the apoptotic process observed in the human fetal adrenal gland and could participate in the morphological changes occurring after birth, leading to involution of the fetal zone.
引用
收藏
页码:4722 / 4730
页数:9
相关论文
共 70 条
  • [61] MICROSCALE AUTORADIOGRAPHIC METHOD FOR THE QUALITATIVE AND QUANTITATIVE-ANALYSIS OF APOPTOTIC DNA FRAGMENTATION
    TILLY, JL
    HSUEH, AJW
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (03) : 519 - 526
  • [62] ANGIOTENSIN-II RECEPTOR SUBTYPES IN FETAL TISSUES OF THE RAT - AUTORADIOGRAPHY, GUANINE-NUCLEOTIDE SENSITIVITY, AND ASSOCIATION WITH PHOSPHOINOSITIDE HYDROLYSIS
    TSUTSUMI, K
    STROMBERG, C
    VISWANATHAN, M
    SAAVEDRA, JM
    [J]. ENDOCRINOLOGY, 1991, 129 (02) : 1075 - 1082
  • [63] Inhibition of cell proliferation and activation of protein tyrosine phosphatase mediated by angiotensin II type 2 (AT(2)) receptor in R3T3 cells
    Tsuzuki, S
    Eguchi, S
    Inagami, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (03) : 825 - 830
  • [64] Integrins (alpha 7 beta 1) in muscle function and survival - Disrupted expression in merosin-deficient congenital muscular dystrophy
    Vachon, PH
    Xu, H
    Liu, L
    Loechel, F
    Hayashi, Y
    Arahata, K
    Reed, JC
    Wewer, UM
    Engvall, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (07) : 1870 - 1881
  • [65] Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells
    Velmuri, GS
    Zhang, J
    Huang, RS
    Keen, JH
    Rittenhouse, SE
    [J]. BIOCHEMICAL JOURNAL, 1996, 314 : 805 - 810
  • [66] Tissue remodelling in the adrenal gland
    Wolkersdorfer, GW
    Bornstein, SR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 56 (02) : 163 - 171
  • [67] Differential regulation of apoptosis in the normal human adrenal gland
    Wolkersdorfer, GW
    EhrhartBornstein, M
    Brauer, S
    Marx, C
    Scherbaum, WA
    Bornstein, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) : 4129 - 4136
  • [68] Detection of monocyte chemoattractant protein-1 (MCP-1) and its receptors in mesangial proliferative glomerulonephritis
    Yamauchi, F
    Kashem, A
    Endoh, M
    Nomoto, Y
    Sakai, H
    [J]. NEPHROLOGY, 1996, 2 (02) : 93 - 99
  • [69] Angiotensin II induces ovulation and oocyte maturation in rabbit ovaries via the AT(2) receptor subtype
    Yoshimura, Y
    Karube, M
    Aoki, H
    Oda, T
    Koyama, N
    Nagai, A
    Akimoto, Y
    Hirano, H
    Nakamura, Y
    [J]. ENDOCRINOLOGY, 1996, 137 (04) : 1204 - 1211
  • [70] ZEMEL S, 1990, J CLIN ENDOCR METAB, V71, P1003, DOI 10.1210/jcem-71-4-1003